Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmaceutical development for treating pancreatic diseases

M Kitagawa1, S Naruse, H Ishiguro

  • 1Department of Internal Medicine II, Nagoya University School of Medicine, Japan.

Pancreas
|April 21, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized, double-blind, placebo-controlled phase II study of olanzapine-based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B).

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing.

ESMO open·2024
Same author

Publisher Correction: The understanding of congruent and incongruent referential gaze in 17-month-old infants: an eye-tracking study comparing human and robot.

Scientific reports·2020
Same author

The understanding of congruent and incongruent referential gaze in 17-month-old infants: an eye-tracking study comparing human and robot.

Scientific reports·2020
Same author

Network meta-analysis of the relative efficacy of bariatric surgeries for diabetes remission.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2018
Same author

Role of fatty liver in the association between obesity and reduced hepatic insulin clearance.

Diabetes & metabolism·2018
Same journal

Efficacy and Safety of Remimazolam versus Midazolam for Sedation during Endoscopic Ultrasound-Guided Tissue Acquisition in Patients with Solid Pancreatic Lesions.

Pancreas·2026
Same journal

Outcomes of Surveillance Program for Individuals at High-Risk of Pancreatic Adenocarcinoma.

Pancreas·2026
Same journal

ITGB4 Activates the Pentose Phosphate Pathway to Reduce the Sensitivity of Pancreatic Adenocarcinoma to Gemcitabine.

Pancreas·2026
Same journal

AI-driven Test-Free Prediction of ICU Admission, Insulin Dependence, and Exocrine Dysfunction after Acute Pancreatitis.

Pancreas·2026
Same journal

Redefining Prognosis in Acute Pancreatitis: The Emerging Role of Antioxidant Biomarkers.

Pancreas·2026
Same journal

Commentary on "High Rate of Exocrine Pancreatic Dysfunction in Pediatric Patients with Diabetes Mellitus".

Pancreas·2026
See all related articles

Treating pancreatic diseases with medications is challenging, as clinical trial evidence often lags behind experimental findings. Current treatments for acute and chronic pancreatitis lack sufficient data for standard care recommendations, necessitating further research.

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Medication efficacy for pancreatic diseases faces challenges in clinical validation.
  • Existing treatments for acute and chronic pancreatitis lack robust clinical trial support.

Purpose of the Study:

  • To review current therapeutic strategies for acute and chronic pancreatitis.
  • To evaluate the evidence supporting various pharmacological interventions and procedures.

Main Methods:

  • Literature review of experimental and clinical studies on pancreatic disease treatments.
  • Analysis of data regarding prophylactic antibiotics, somatostatin, protease inhibitors, and CCK-receptor antagonists.

Main Results:

  • Evidence for prophylactic antibiotics, somatostatin, protease inhibitors, and CCK-receptor antagonists in acute pancreatitis is insufficient for standard care.

Related Experiment Videos

  • Treatments for chronic pancreatitis and pancreatic stones exist but require further evaluation.

    • Conclusions:

    • Current therapeutic options for pancreatic diseases require more rigorous clinical trials.
    • Promising treatments need prospective comparison and long-term evaluation to establish standard care protocols.